Intrinsic Periodic Pattern of Breathing (PERHYP1)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02201875|
Recruitment Status : Unknown
Verified July 2014 by Pr. Jean Paul RICHALET, Association pour la Recherche en Physiologie de l'Environnement.
Recruitment status was: Not yet recruiting
First Posted : July 28, 2014
Last Update Posted : July 28, 2014
We made a fortuitous observation of periodic breathing in a healthy subject coming to our outpatient mountain medicine consultation at Avicenne hospital in Bobigny (France). During this consultation, subjects perform a hypoxia exercise test, which allows a good prediction of their risk factors for severe high altitude illnesses. Surprisingly, breath-by-breath recording of the ventilation signal showed a periodic breathing pattern, which increased when the subject started to exercise in hypoxic conditions and was maintained during normoxic exercise.
Therefore, our objective was to confirm this observation in a retrospective study led in 82 subjects who passed this test. We tested the hypothesis that subjects with a brisk ventilatory response to hypoxia might show a more pronounced periodic pattern of ventilation, due to a higher gain of the chemoreceptor feedback loop. Then, our objective is to investigate the mechanisms involved in the periodic pattern in healthy subjects, as a function of exercise intensity, altitude intensity, role of peripheral and central chemoreceptors to O2 and CO2. Finally, we want to investigate the possible role of this ventilatory instability in patients with obstructive or central apneas.
|Condition or disease|
|Normoxia Hypoxia Hyperoxia Hypercapnia|
In a preliminary study, among the population coming to the outpatient consultation of mountain medicine at Avicenne hospital in 2012, 82 subjects (38 females and 44 males) were randomly selected and separated in two groups of 41 high and 41 low responders to hypoxia according to the median value of the hypoxic ventilatory response to hypoxia at exercise (HVRe > or < 0.84 L/min/kg) derived from the hypoxic exercise test (inspired fraction of O2: 0.115, exercise intensity of 30% of maximal aerobic power), as previously described.
The hypoxic exercise test consists in 4 successive phases of 3 to 4 minutes each with the following sequence: rest in normoxia (RN), rest in hypoxia (RH), exercise in hypoxia (EH) and exercise in normoxia (EN). Minute ventilation ( E, L.min-1) is measured through a metabograph (Vmax Encore, SensorMedics, Yorba Linda, CA). Pulse O2 saturation (SpO2, %) is measured by transcutaneous oximetry (Nellcor N-595, Nellcor, Pleasanton, CA) on a pre-warmed ear lobe. End tidal PCO2 (PETCO2) is measured by infrared thermopile (Vmax Encore, SensorMedics, Yorba Linda, CA). During the whole test, VE, SpO2 and PETCO2 were recorded breath-by-breath. Continuous blood pressure is measured by a Finapres system. Data are transferred to a computer for further spectrum analysis. A Fast Fourier Transform (FFT) is then applied to the ventilation signal in sequences of 128 points in each phase of the test. This method will allow us to detect the presence of peaks in the frequency domain of the ventilation signal. Two main parameters are derived from the FFT: the frequency in hertz (or period in seconds) of the larger peak and its power estimated as the area under the peak at ± 0.02 Hz around the peak (in L2.s-2).
The main study will be designed in order to unravel the mechanisms and role of these oscillations in ventilation. An overall population of 90 healthy subjects and 30 patients will be included in the study.
Step 1. Effect of exercise intensity.
Step 2. Effect of altitude level.
Step 3. Effect of the stimulation of central chemoreceptors by acetazolamide.
Step 4. Effect of inhibiting the peripheral chemoreceptors by hyperoxia.
Step 5. Effect of inhibiting the peripheral chemoreceptors by hyperoxia and stimulating the central chemoreceptors by hypercapnia.
Step 6. Evaluating the presence of these oscillations in patients with sleep apneas.
Step 7. Evaluating the presence of these oscillations in patients with cardiac failure.
|Study Type :||Observational|
|Estimated Enrollment :||120 participants|
|Official Title:||Study of Periodic Breathing in Healthy Humans|
|Study Start Date :||September 2014|
|Estimated Primary Completion Date :||June 2015|
|Estimated Study Completion Date :||December 2015|
male, aged 18-65 moderately trained healthy, no treatment
obstructive sleep apneas
patients with apnea/hypopnea index > 15 BMI < 30 Age < 50 yrs
NYHA class I to III ejection fraction < 40% age < 65 yrs BMI < 30
- Periodic pattern of ventilation [ Time Frame: The measure is made at the end of the 6-min exercise period, only once in each condition (normoxia, hypoxia, hyperoxia, hypercapnia), ]Presence of oscillation in the ventilation signal
- Oscillations in heart rate [ Time Frame: The measure is made at the end of the 6-min exercise period, only once in each condition (normoxia, hypoxia, hyperoxia, hypercapnia) ]Presence of oscillations in the beat-by-beat ECG signal with a specific peak in the frequency spectrum
- Oscillations in arterial blood pressure [ Time Frame: The measure is made at the end of the 6-min exercise period, only once in each condition (normoxia, hypoxia, hyperoxia, hypercapnia) ]Presence of oscillations in the systolic/diastolic value of instant arterial blood pressure, measured non-invasively.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02201875
|Contact: Jean-Paul Richalet, MD, PhDemail@example.com|
|Bobigny, France, 93009|
|Contact: Jean-Paul Richalet, MD, PhD 33148387758 firstname.lastname@example.org|
|Principal Investigator: Jean-Paul Richalet, MD, PhD|
|Sub-Investigator: François J Lhuissier, MD, PhD|
|Sub-Investigator: Carole Planès, MD, PhD|
|Sub-Investigator: Christophe Meune, MD, PhD|